Quarterly report [Sections 13 or 15(d)]

Discontinued Operations - Schedule of Reconciliation of Discontinued Operations (Details)

v3.25.2
Discontinued Operations - Schedule of Reconciliation of Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Income (loss) from discontinued operations $ 0 $ (690) $ 8,644 $ (1,431)
Discontinued Operations, Disposed of by Sale | Pharmaloz        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenues, net 0 970 0 2,248
Cost of revenues 0 1,291 0 2,942
Gross loss 0 (321) 0 (694)
Operating expenses:        
General and administration 0 278 102 572
Research and development 0 0 0 0
Total operating expenses 0 278 102 572
Loss from operations 0 (599) (102) (1,266)
Interest expense 0 (121) 0 (195)
Other income 0 30 0 30
Income (loss) from discontinued operations $ 0 $ (690) $ (102) $ (1,431)